Final Assessment

The ACOG District II 2013 Annual Meeting provides the opportunity to facilitate the professional development of women’s health care professionals by offering a scientific program designed to provide comprehensive clinical skills-based education.

District II’s mission is to provide its members with the latest skills, knowledge, and resources to offer the highest quality health care for women.

Over the past three days, participants have engaged in an interactive program that included:

* Ample case studies
* Group and panel discussions
* Compelling presentations from distinguished faculty across the country

Please complete this Final Assessment to help inform future programming.

Question Title

* 1. Yvonne Thornton, MD, MPH, FACOG, FACS

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 2. Disclosed whether or not relationship with industry exists

Question Title

* 3. Would you like to hear this speaker again?

Question Title

* 4. Scott Hayworth, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 5. Disclosed whether or not relationship with industry exists

Question Title

* 6. Would you like to hear this speaker again?

Question Title

* 7. James N. Martin, Jr., MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 8. Disclosed whether or not relationship with industry exists

Question Title

* 9. Would you like to hear this speaker again?

Question Title

* 10. Mark S. Defrancesco, MD, MBA, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 11. Disclosed whether or not relationship with industry exists

Question Title

* 12. Would you like to hear this speaker again?

Question Title

* 13. Mary E. D'Alton, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 14. Disclosed whether or not relationship with industry exists

Question Title

* 15. Would you like to hear this speaker again?

Question Title

* 16. John P. Keats, MD, CPE, FACOG, FACPE

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 17. Disclosed whether or not relationship with industry exists

Question Title

* 18. Would you like to hear this speaker again?

Question Title

* 19. Cynthia Chazotte, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 20. Disclosed whether or not relationship with industry exists

Question Title

* 21. Would you like to hear this speaker again?

Question Title

* 22. Ronald T. Burkman, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 23. Disclosed whether or not relationship with industry exists

Question Title

* 24. Would you like to hear this speaker again?

Question Title

* 25. Jason D. Wright, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 26. Disclosed whether or not relationship with industry exists

Question Title

* 27. Would you like to hear this speaker again?

Question Title

* 28. Mark I. Evans, MD, FACOG, FACMG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 29. Disclosed whether or not relationship with industry exists

Question Title

* 30. Would you like to hear this speaker again?

Question Title

* 31. Susan Klugman, MD, FACOG, FACMG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 32. Disclosed whether or not a relationship with industry exists

Question Title

* 33. Would you like to hear this speaker again?

Question Title

* 34. Noah D. Kauff, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 35. Disclosed whether or not relationship with industry exists

Question Title

* 36. Would you like to hear this speaker again?

Question Title

* 37. Angela G. Arnold, MS, CGC

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 38. Disclosed whether or not relationship with industry exists

Question Title

* 39. Would you like to hear this speaker again?

Question Title

* 40. Robert A. Soslow, MD

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 41. Disclosed whether or not relationship with industry exists

Question Title

* 42. Would you like to hear this speaker again?

Question Title

* 43. Laura MacIsaac, MD, MPH, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 44. Disclsoed whether or not relationship with industry exists

Question Title

* 45. Would you like to hear this speaker again?

Question Title

* 46. Anthony T. DiBenedetto, MD, FACS

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 47. Disclsoed whether or not relationship with industry exists

Question Title

* 48. Would you like to hear this speaker again

Question Title

* 49. Andrew M. Kaunitz, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 50. Disclosed whether or not relationship with industry exists

Question Title

* 51. Would you like to hear this speaker again?

Question Title

* 52. Kunle Odunsi, MD, PhD

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 53. Disclosed whether or not relationship with industry exists

Question Title

* 54. Would you like to hear this speaker again?

Question Title

* 55. Haywood L. Brown, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 56. Disclsoed whether or not relationship with industry exists

Question Title

* 57. Would you like to hear this speaker again?

Question Title

* 58. Yitzchak M. Binik, PhD

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 59. Disclosed whether or not relationship with industry exists

Question Title

* 60. Would you like to hear this speaker again?

Question Title

* 61. Linda Bradley, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 62. Disclosed whether or not relationship with industry exists

Question Title

* 63. Would you like to hear this speaker again?

Question Title

* 64. Nicholas Kulbida, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 65. Disclosed whether or not relationship with industry exists

Question Title

* 66. Would you like to hear this speaker again?

Question Title

* 67. Joanne Stone, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 68. Disclosed whether or not relationship with industry exists

Question Title

* 69. Would you like to hear this speaker again?

Question Title

* 70. James Goldberg, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 71. Disclosed whether or not relationship with industry exists

Question Title

* 72. Would you like to hear this speaker again?

Question Title

* 73. Cynthia Gymafi-Bannerman, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 74. Disclosed whether or not relationship with industry exists

Question Title

* 75. Would you like to hear this speaker again?

Question Title

* 76. Angela Bianco, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 77. Disclosed whether or not relationship wtih industry exists

Question Title

* 78. Would you like to hear this speaker again?

Question Title

* 79. Richard L. Berkowitz, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 80. Disclosed whether ot not relationship with industry exists

Question Title

* 81. Would you like to hear this speaker again?

Question Title

* 82. Elliott K. Main, MD, FACOG

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 83. Disclosed whether or not relationship with faculty exists

Question Title

* 84. Would you like to hear this speaker again?

Question Title

* 85. "Ask the Experts" Panel Discussion

  1 (poor) 2 3 4 5 (excellent)
Was understandable (speed, diction, volume)
Kept within time limits
Made no inappropriate remarks
Appeared not to have a commercial bias

Question Title

* 86. Disclosed whether or not relationship with industry exists

Question Title

* 87. Would you like to hear this speaker again?

Question Title

* 88. This program was:

Question Title

* 89. The entire program...

  1 (strongly disagree) 2 3 4 5 (strongly agree)
Was well-organized
Was consistent with course objectives
Allowed sufficient time for discussion
Adhered to printed meeting schedule
Meeting facilities were conducive to learning

Question Title

* 90. Final program grade (5 = best score)

Question Title

* 91. The hotel facilities

  1 (very dissatisfied) 2 3 4 5 (very satisfied)
How satisfied were you with this facility?
How satisfied were you with the cost of this facility?

Question Title

* 92. Preferred topics for future courses (indicate if of interest to you):

Question Title

* 93. What is your preferred meeting site? (indicate one)

Question Title

* 94. What is your preferred meeting region?

Question Title

* 95. What are the factors influencing your choice?

  Yes No
Hotel costs
Course content
Availability of direct transportation
Facilities for family

Question Title

* 96. Preferred meeting days: the meeting should start on...

Question Title

* 97. COMMENTS: If you have comments on any aspects of this program that were not covered by this evaluation, please write them within this box.

T